Kontafarma China Holdings Issues Significant Profit Warning for FY2025

Key Points Investors Must Know

• Massive Net Loss Expected: Kontafarma China Holdings Limited (“Company”) anticipates a consolidated net loss ranging between HK\$414.1 million and HK\$506.2 million for the financial year ending 31 December 2025, compared to a net loss of approximately HK\$99.0 million in the previous year.
• Impairment Losses Drive Losses: The sharp increase in losses is primarily due to major impairment losses related to the Company’s fitness business.
• Key Impairment Details:
  • Expected credit loss model on financial assets: HK\$169.3 million.
  • Impairment on intangible assets: HK\$123.9 million.
  • Impairment on goodwill related to fitness business: HK\$100.4 million to HK\$122.7 million.
• Franchise Fitness Business in Taiwan Ceased Operations: The cessation of franchise fitness operations in Taiwan is a significant event, linked to operational difficulties and cash flow constraints in True Concept Ltd. (全真概念健康事業股份有限公司), in which the Company holds a 29% indirect equity interest.
• Possible Winding Up of True Concept Ltd.: As of 1 October 2025, all fitness centers operated by True Concept have ceased operations. Legal proceedings for winding up True Concept have not yet commenced, but this remains a risk for the Company.
• Challenging Singapore Market: The Company’s fitness business in Singapore is facing slow recovery and heightened competition, further pressuring the Group’s financial performance.
• Preliminary Figures: All figures are based on management’s preliminary assessment and unaudited accounts. The final audited results will be announced by end of March 2026 and may differ.

Important Shareholder and Investor Information

• Price Sensitive: The expected net loss for FY2025 is over four times greater than the previous year’s loss. This represents a material deterioration in financial performance and is likely to be highly price sensitive.
• Operational Risks: The cessation and possible winding up of the Taiwanese fitness business, coupled with weak performance in Singapore, signal ongoing operational risks, asset impairments, and uncertainty regarding future recovery.
• Board Composition: As of the announcement date, the Board consists of three executive directors (including Chairman and President Mr. Wang Feifei), one non-executive director, and three independent non-executive directors.
• Investor Warning: Shareholders and potential investors are strongly advised to exercise caution when dealing in the Company’s securities, given the preliminary nature of the financials and the significant risks highlighted.

Detailed Breakdown of Impairment Losses

• Impairment Losses on Financial Assets: HK\$169.3 million attributed to expected credit losses, reflecting deteriorating recoverability of receivables and other financial assets.
• Impairment on Intangible Assets: HK\$123.9 million, likely resulting from write-downs of brand and franchise value following the closure of fitness centers.
• Impairment of Goodwill: Between HK\$100.4 million and HK\$122.7 million, linked to the fitness business segment, reflecting a reassessment of future cash flows and value of acquired operations.

Background on True Concept Ltd. and Potential Legal Proceedings

• The Company indirectly owns a 29% stake in True Concept Ltd., which operated franchise fitness centers in Taiwan.
• Due to operational and cash flow difficulties, True Concept ceased all operations as of 1 October 2025.
• As of the announcement date, legal proceedings for winding up True Concept have not yet started, but this remains a risk for the Company’s investment and asset base.

Expected Timeline for Final Results

The Company expects to announce its final audited consolidated results for FY2025 by the end of March 2026. The figures provided in this profit warning are subject to change pending audit and review.

Conclusion

This profit warning represents a material event for Kontafarma China Holdings Limited, involving significant asset impairments, operational shutdowns, and a marked decline in financial performance. The situation is highly price sensitive and investors should monitor subsequent announcements closely.

Disclaimer

The information in this article is based on preliminary unaudited management accounts and Company disclosures. Actual results may differ after audit and review. This article does not constitute investment advice. Investors should exercise caution and seek professional advice before making any investment decisions.

View KONTA CHINA Historical chart here